Broad-spectrum antiviral drug could inhibit coronaviruses
A collaborative study by American institutions has identified a novel antiviral drug candidate that could inhibits a broad range of coronaviruses, including the SARS and MERS coronaviruses. These findings support further development of the drug candidate for treating and preventing current coronavirus infections and potential future epidemic outbreaks.
Please sign in or register for FREE to view this content
Sign in to MedChemNet
Register to MedChemNet – the medicinal chemistry network
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.